Project Versive
Our aim is to revolutionize manual wheelchair mobility with steering-by-leaning, a principle to control direction without breaking.
Project Veltist
Our aim is to develop an advanced sealant patch to mitigate and eradicate postoperative digestive fluid leaks, a common and often deadly complication following surgeries on abdominal cavity organs.
Adularia AG
Our aim is to leverage the natural metabolic interplay between the human immune system, the microbiome, and disease onset to develop molecule therapies that enhance the body’s native immune response against cancer.
MYNERVA AG
Our aim is to develop an innovative neurostimulating medical device to reduce chronic pain and to restore the sense of touch in patients suffering from diabetic neuropathy.
Somagenetix AG
Our aim is to develop a lentiviral-based gene therapy using patient-derived stem cells from bone marrow to correct congenital gene defects.
Tandem Therapeutics AG
Our aim is to develop novel peptide drug conjugates specifically designed to target the fibrotic matrix to potentially arrest fibrotic progression.
mint & pepper
Our aim is to awaken children’s interest early and to boost teenagers’ enthusiasm for apprenticeships, research, and professional careers in STEM (Science Technology Engineering and Mathematics) fields – in German referred to as MINT (Mathematik, Informatik, Naturwissenschaften und Technologie).
ATLyphe AG
The novel bispecific T-cell engaging antibody has the potential to transform current hematopoietic stem cell transplantation practice into an immunologic precision-medicine approach.
LifeMatrix Technologies AG
Our aim is to develop a unique tissue engineering technology to grow replacement tissue in the laboratory that is compatible with any patient and that regenerates and grows with the recipient.